Qingdao Baheal Medical INC.

¥25.62As of Sun 8 Nov 2026, 12:00 UTC
SZSE:301015Healthcare
Country China
PE (Fwd) •••
TSR 5Y CAGR (11.15%)
Div yield 2.23%
ROE 11.69%
Medical Distribution
Beta (5Y) 0.21
PE TTM 56.59
TSR TTM (1.79%)
Mkt cap ¥13.47B
ROIC 8.86%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥25
(1.24%)
67.73%
Hold 0|10|1|2|5
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.29
0.29
0.30
0.33
19.60%
9.77%
10.46%
23.49%
Revenue¥B
1.125
1.110
1.148
1.191
2.95%
(3.50%)
(1.58%)
3.10%
Peers (US$2.019B)
Cap (US$)
PE
1.989B
14.39x
Capital
TTM
5Y
10Y
Leveragex
0.856
0.779
0.586
EBIT/Intx
3.934
0.066
0.071
Own earn%
(1541.41)
(26.01)
(36.13)
Sh yield%
30.52
23.87
20.05
Owners
Insiders/Inst%
8.58
76.06
Short interest%
2.58
SBC / revenue%
3.69
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
1
Op margin range%
18–22
$1 testx
—
Incr. ROIC%
5